High-risk human papillomavirus (HPV) is now recognised as the principal cause of the
increasing incidence rates of oropharyngeal squamous cell carcinoma (OPSCC) in some …

This chapter addresses the natural history of anogenital human papillomavirus (HPV)
infection. Cervical infections are the best understood HPV infection. Cervical HPV …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Background The quadrivalent human papillomavirus (HPV) vaccine was shown to prevent
infections and lesions related to HPV6, 11, 16, and 18 in a randomised, placebo-controlled …

Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …

To provide updates for the 2015 Centers for Disease Control and Prevention sexually
transmitted diseases treatment guidelines on human papillomavirus (HPV) and anogenital …

Individuals with human papillomavirus (HPV)-related disease remain at risk for subsequent
HPV infection and related disease after treatment of specific lesions. Prophylactic HPV …

Context Whether androgen deprivation therapy (ADT) causes excess cardiovascular deaths
in men with prostate cancer is highly controversial and was the subject of a joint statement …

Background Oral human papillomavirus (HPV) infection causes a subset of oropharyngeal
cancers. These cancers disproportionately affect men, are increasing in incidence, and have …

Background: Human papillomavirus (HPV) infection is considered as the most common viral
sexually transmitted infection worldwide. This poses an increasingly interdisciplinary …